A comprehensive view of Epidemic / Pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Forestry & Timberland Market Intelligence Service.
Freedonia forecasts global infection protection products market to grow 3.5%/year to US$58.5B in 2027, and rise 4.2%/year to US$71.7B by 2032; market includes sterilization products, cleaning and disinfection products, protection barriers, other products
Published:
April 25, 2024
by The Freedonia Group Inc.
|
GlobalData: Success of mRNA vaccine technology during Covid-19 pandemic could lead to using platform to reduce preventable illness across multiple disease areas; about 507 preventive vaccines in late-stage development, with 88 using mRNA technology
Published:
April 24, 2024
by Indo-Asian News Service
|
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published:
April 24, 2024
by CE Noticias Financieras (Latin America)
|
Roche reports group sales increase by 2% year-over-year due to the success of newer medicines and diagnostics, independent of COVID-19 products; the surge was offset by the strengthening of the Swiss franc and a decline in COVID-19 test demand
Published:
April 24, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Moderna brings Pfizer/BioNTech to court in London claiming patent breach over COVID-19 vaccine technology; Pfizer and BioNTech deny the allegations and call for two Moderna patents to be declared invalid
Published:
April 23, 2024
by AFP World News
|
Ask us about our Forestry & Timberland market view